These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 28405899)

  • 1. The Quality of Clinical Information in Adverse Drug Reaction Reports by Patients and Healthcare Professionals: A Retrospective Comparative Analysis.
    Rolfes L; van Hunsel F; van der Linden L; Taxis K; van Puijenbroek E
    Drug Saf; 2017 Jul; 40(7):607-614. PubMed ID: 28405899
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Awareness, knowledge, attitude and practice of adverse drug reaction reporting among health workers and patients in selected primary healthcare centres in Ibadan, southwestern Nigeria.
    Adisa R; Omitogun TI
    BMC Health Serv Res; 2019 Dec; 19(1):926. PubMed ID: 31796034
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparing patients' and healthcare professionals' ADR reports after media attention: the broadcast of a Dutch television programme about the benefits and risks of statins as an example.
    van Hunsel F; Passier A; van Grootheest K
    Br J Clin Pharmacol; 2009 May; 67(5):558-64. PubMed ID: 19552751
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Patient versus healthcare professional spontaneous adverse drug reaction reporting: a systematic review.
    Inch J; Watson MC; Anakwe-Umeh S
    Drug Saf; 2012 Oct; 35(10):807-18. PubMed ID: 22928729
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Safety Concerns Reported by Patients Identified in a Collaborative Signal Detection Workshop using VigiBase: Results and Reflections from Lareb and Uppsala Monitoring Centre.
    Watson S; Chandler RE; Taavola H; Härmark L; Grundmark B; Zekarias A; Star K; van Hunsel F
    Drug Saf; 2018 Feb; 41(2):203-212. PubMed ID: 28933055
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evaluation of completeness of suspected adverse drug reaction reports submitted to the mexican national pharmacovigilance centre: a cross-sectional period-prevalence study.
    Sánchez-Sánchez B; Altagracia-Martínez M; Kravzov-Jinich J; Moreno-Bonett C; Vázquez-Moreno E; Martínez-Núñez JM
    Drug Saf; 2012 Oct; 35(10):837-44. PubMed ID: 22924896
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A Retrospective Review of Serious Adverse Drug Reaction Reports in the Nigerian VigiFlow Database from September 2004 to December 2016.
    Ogar CK; Abiola A; Yuah D; Ibrahim A; Oreagba IA; Amadi EC; Adeyeye MC; Oshikoya KA
    Pharmaceut Med; 2019 Apr; 33(2):145-157. PubMed ID: 31933250
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Expectations for feedback in adverse drug reporting by healthcare professionals in the Netherlands.
    Oosterhuis I; van Hunsel FP; van Puijenbroek EP
    Drug Saf; 2012 Mar; 35(3):221-32. PubMed ID: 22201474
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Exploring the factors and barriers of healthcare professionals in tertiary care hospitals toward pharmacovigilance: a multicenter study from Khyber Pakhtunkhwa, Pakistan.
    Sharif MJH; Farrukh MJ; Khan FU; Khan Q; Ahmed SS; Kousar R; Ahmad T; Abid SMA; Ashfaq M; Khan SA
    Curr Med Res Opin; 2022 Apr; 38(4):595-605. PubMed ID: 35166143
    [TBL] [Abstract][Full Text] [Related]  

  • 10. First French experience of ADR reporting by patients after a mass immunization campaign with Influenza A (H1N1) pandemic vaccines: a comparison of reports submitted by patients and healthcare professionals.
    Durrieu G; Palmaro A; Pourcel L; Caillet C; Faucher A; Jacquet A; Ouaret S; Perault-Pochat MC; Kreft-Jais C; Castot A; Lapeyre-Mestre M; Montastruc JL;
    Drug Saf; 2012 Oct; 35(10):845-54. PubMed ID: 22967189
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Medical students as adverse drug event managers, learning about side effects while improving their reporting in clinical practice.
    Reumerman M; Tichelaar J; Richir MC; van Agtmael MA
    Naunyn Schmiedebergs Arch Pharmacol; 2021 Jul; 394(7):1467-1476. PubMed ID: 33666715
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evaluation of patient reporting of adverse drug reactions to the UK 'Yellow Card Scheme': literature review, descriptive and qualitative analyses, and questionnaire surveys.
    Avery AJ; Anderson C; Bond CM; Fortnum H; Gifford A; Hannaford PC; Hazell L; Krska J; Lee AJ; McLernon DJ; Murphy E; Shakir S; Watson MC
    Health Technol Assess; 2011 May; 15(20):1-234, iii-iv. PubMed ID: 21545758
    [TBL] [Abstract][Full Text] [Related]  

  • 13. First experiences with a tool to measure the level of clinical information present in adverse drug reaction reports.
    Oosterhuis I; Rolfes L; Ekhart C; Muller-Hansma A; Härmark L
    Expert Opin Drug Saf; 2018 Feb; 17(2):111-115. PubMed ID: 29157026
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Online reporting of adverse drug reactions: a study from a French regional pharmacovigilance center.
    Abadie D; Chebane L; Bert M; Durrieu G; Montastruc JL
    Therapie; 2014; 69(5):395-400. PubMed ID: 25269141
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Bulgarian Experience with Adverse Drug Reaction Reports from Patients and Consumers - Retrospective Data-base Study.
    Getova VI; Georgiev SR; Stoimenova AH; Petkova-Georgieva ES
    Folia Med (Plovdiv); 2018 Sep; 60(3):447-453. PubMed ID: 30355838
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Why hospital-based healthcare professionals do not report adverse drug reactions: a mixed methods study using the Theoretical Domains Framework.
    Li R; Curtis K; Van C; Tabish Razi Zaidi S; Yeo CY; Arun Kali C; Zaheen M; Therese Moujalli G; Castelino R
    Eur J Clin Pharmacol; 2022 Jul; 78(7):1165-1175. PubMed ID: 35476123
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Under-reporting of adverse drug reactions: a challenge for pharmacovigilance in India.
    Tandon VR; Mahajan V; Khajuria V; Gillani Z
    Indian J Pharmacol; 2015; 47(1):65-71. PubMed ID: 25821314
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Factors associated with spontaneous adverse drug reaction reporting among healthcare professionals in Vietnam.
    Le TT; Nguyen TTH; Nguyen C; Tran NH; Tran LA; Nguyen TB; Nguyen N; Nguyen HA
    J Clin Pharm Ther; 2020 Feb; 45(1):122-127. PubMed ID: 31486525
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Healthcare professionals' knowledge, attitude and practice towards adverse drug reaction (ADR) reporting at the health center level in Ethiopia.
    Seid MA; Kasahun AE; Mante BM; Gebremariam SN
    Int J Clin Pharm; 2018 Aug; 40(4):895-902. PubMed ID: 30094559
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Knowledge, attitudes and practice regarding pharmacovigilance and adverse drug reaction reporting among physicians and pharmacists in Egypt: a step toward personalized medicine implementation.
    Aziz AA; Rogers S; Hassanien O; Shalaby L; Nagy M
    Per Med; 2022 Nov; 19(6):495-507. PubMed ID: 36239598
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.